Literature DB >> 29882226

Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnoea.

Ludovico Messineo1,2, Luigi Taranto-Montemurro1, Ali Azarbarzin1, Melania D Oliveira Marques1,3, Nicole Calianese1, David P White1, Andrew Wellman1, Scott A Sands1,4.   

Abstract

KEY POINTS: A hypersensitive ventilatory control system or elevated "loop gain" during sleep is a primary phenotypic trait causing obstructive sleep apnoea (OSA). Despite the multitude of methods available to assess the anatomical contributions to OSA during wakefulness in the clinical setting (e.g. neck circumference, pharyngometry, Mallampati score), it is currently not possible to recognize elevated loop gain in patients in this context. Loop gain during sleep can now be recognized using simplified testing during wakefulness, specifically in the form of a reduced maximal breath-hold duration, or a larger ventilatory response to voluntary 20-second breath-holds. We consider that easy breath-holding manoeuvres will enable daytime recognition of a high loop gain in OSA for more personalized intervention. ABSTRACT: Increased "loop gain" of the ventilatory control system promotes obstructive sleep apnoea (OSA) in some patients and offers an avenue for more personalized treatment, yet diagnostic tools for directly measuring loop gain in the clinical setting are lacking. Here we test the hypothesis that elevated loop gain during sleep can be recognized using voluntary breath-hold manoeuvres during wakefulness. Twenty individuals (10 OSA, 10 controls) participated in a single overnight study with voluntary breath-holding manoeuvres performed during wakefulness. We assessed (1) maximal breath-hold duration, and (2) the ventilatory response to 20 s breath-holds. For comparison, gold standard loop gain values were obtained during non-rapid eye movement (non-REM) sleep using the ventilatory response to 20 s pulses of hypoxic-hypercapnic gas (6% CO2 -14% O2 , mimicking apnoea). Continuous positive airway pressure (CPAP) was used to maintain airway patency during sleep. Additional measurements included gold standard loop gain measurement during wakefulness and steady-state loop gain measurement during sleep using CPAP dial-ups. Higher loop gain during sleep was associated with (1) a shorter maximal breath-hold duration (r2  = 0.49, P < 0.001), and (2) a larger ventilatory response to 20 s breath-holds during wakefulness (second breath; r2  = 0.50, P < 0.001); together these factors combine to predict high loop gain (receiver operating characteristic area-under-curve: 92%). Gold standard loop gain values were remarkably similar during wake and non-REM sleep. The results show that elevated loop gain during sleep can be identified using simple breath-holding manoeuvres performed during wakefulness. This may have implications for personalizing OSA treatment.
© 2018 Brigham and Women's Hospital and Harvard Medical School. The Journal of Physiology © 2018 The Physiological Society.

Entities:  

Keywords:  OSA alternative treatments; OSA phenotyping; chemoreflex predictors

Mesh:

Year:  2018        PMID: 29882226      PMCID: PMC6117550          DOI: 10.1113/JP276206

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  43 in total

1.  Estimation of chemoreflex loop gain using pseudorandom binary CO2 stimulation.

Authors:  S D Ghazanshahi; M C Khoo
Journal:  IEEE Trans Biomed Eng       Date:  1997-05       Impact factor: 4.538

2.  SAVE trial: no cardiovascular benefits for CPAP in OSA.

Authors:  Bryant Furlow
Journal:  Lancet Respir Med       Date:  2016-09-21       Impact factor: 30.700

3.  Occlusion pressure and ventilation during sleep in normal humans.

Authors:  D P White
Journal:  J Appl Physiol (1985)       Date:  1986-10

4.  Hypercapnic ventilatory response in sleeping adults.

Authors:  N J Douglas; D P White; J V Weil; C K Pickett; C W Zwillich
Journal:  Am Rev Respir Dis       Date:  1982-11

5.  A mechanism of central sleep apnea in patients with heart failure.

Authors:  S Javaheri
Journal:  N Engl J Med       Date:  1999-09-23       Impact factor: 91.245

6.  Residual chemosensitivity to ventilatory challenges in genotyped congenital central hypoventilation syndrome.

Authors:  Michael S Carroll; Pallavi P Patwari; Anna S Kenny; Cindy D Brogadir; Tracey M Stewart; Debra E Weese-Mayer
Journal:  J Appl Physiol (1985)       Date:  2013-12-31

7.  Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study.

Authors:  Ludovico Messineo; Roberto Magri; Luciano Corda; Laura Pini; Luigi Taranto-Montemurro; Claudio Tantucci
Journal:  Sleep Breath       Date:  2017-02-25       Impact factor: 2.816

8.  Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea.

Authors:  Bradley A Edwards; James G Connolly; Lisa M Campana; Scott A Sands; John A Trinder; David P White; Andrew Wellman; Atul Malhotra
Journal:  Sleep       Date:  2013-02-01       Impact factor: 5.849

9.  Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

Authors:  Danny J Eckert; David P White; Amy S Jordan; Atul Malhotra; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

10.  Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure.

Authors:  Alberto Giannoni; Michele Emdin; Francesca Bramanti; Giovanni Iudice; Darrel P Francis; Antonio Barsotti; Massimo Piepoli; Claudio Passino
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094

View more
  13 in total

1.  Integrating loop gain into the understanding of obstructive sleep apnoea mechanisms.

Authors:  Luu V Pham; Alan R Schwartz; Vsevolod Y Polotsky
Journal:  J Physiol       Date:  2018-07-23       Impact factor: 5.182

Review 2.  More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea.

Authors:  Bradley A Edwards; Susan Redline; Scott A Sands; Robert L Owens
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

Review 3.  Update on Chemoreception: Influence on Cardiorespiratory Regulation and Pathophysiology.

Authors:  Jerome A Dempsey; Curtis A Smith
Journal:  Clin Chest Med       Date:  2019-06       Impact factor: 2.878

4.  Breathing rate variability in obstructive sleep apnea during wakefulness.

Authors:  Amrita Pal; Fernando Martinez; Margaret A Akey; Ravi S Aysola; Luke A Henderson; Atul Malhotra; Paul M Macey
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

5.  A Novel Model to Estimate Key Obstructive Sleep Apnea Endotypes from Standard Polysomnography and Clinical Data and Their Contribution to Obstructive Sleep Apnea Severity.

Authors:  Ritaban Dutta; Gary Delaney; Barbara Toson; Amy S Jordan; David P White; Andrew Wellman; Danny J Eckert
Journal:  Ann Am Thorac Soc       Date:  2021-04

6.  It's possible: why don't we do it?

Authors:  Winfried Randerath
Journal:  J Clin Sleep Med       Date:  2021-06-01       Impact factor: 4.324

Review 7.  Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature.

Authors:  Luigi Taranto-Montemurro; Ludovico Messineo; Andrew Wellman
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

8.  Silencing of Hypoglossal Motoneurons Leads to Sleep Disordered Breathing in Lean Mice.

Authors:  Thomaz A Fleury Curado; Huy Pho; Olga Dergacheva; Slava Berger; Rachel Lee; Carla Freire; Aya Asherov; Luis U Sennes; David Mendelowitz; Alan R Schwartz; Vsevolod Y Polotsky
Journal:  Front Neurol       Date:  2018-11-14       Impact factor: 4.003

9.  Angiotensin II-Type I Receptor Antagonism Does Not Influence the Chemoreceptor Reflex or Hypoxia-Induced Central Sleep Apnea in Men.

Authors:  Courtney V Brown; Lindsey M Boulet; Tyler D Vermeulen; Scott A Sands; Richard J A Wilson; Najib T Ayas; John S Floras; Glen E Foster
Journal:  Front Neurosci       Date:  2020-04-28       Impact factor: 4.677

10.  Prior oxygenation, but not chemoreflex responsiveness, determines breath-hold duration during voluntary apnea.

Authors:  Christina D Bruce; Emily R Vanden Berg; Jamie R Pfoh; Craig D Steinback; Trevor A Day
Journal:  Physiol Rep       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.